Monoclonal Antibodies
Anti-Cystatin B Monoclonal Antibody for WB, ELISA - P04080
Item Number : CM0003967
Price varies based on specs and customizations
- Application
- WB, ELISA
- Cross Reactivity
- Human, Mouse, Rat
- Protein Weight
- 11kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | Cystatin B Rabbit mAb |
| Remarks/Alias | PME; ULD; CST6; EPM1; STFB; CPI-B; EPM1A; Cystatin B |
| Species | Human |
| Gene ID (Human) | 1476 |
| Gene ID | 1476 |
| Immunogen | Synthetic peptide: A synthetic peptide corresponding to a sequence within amino acids 1-98 of human Cystatin B (NP_000091.1) |
| Source | Rabbit |
| Category | Monoclonal Antibodies |
| Application | WB, ELISA |
| Cross Reactivity | Human, Mouse, Rat |
| SWISS | P04080 |
| Protein Weight | 11kDa |
| Shipping | Ice bag |
Biological Background: Cystatin B Function and Localization
- Cystatin B (also known as Stefin-B, CPI-B, or liver thiol proteinase inhibitor) is an intracellular protein belonging to the cystatin superfamily of cysteine protease inhibitors.
- It functions as a tight-binding reversible inhibitor of cathepsins L, H, and B, thereby regulating lysosomal cysteine protease activity.
- The protein is encoded by the CSTB gene (also designated CST6 or STFB) and is located on human chromosome 21.
- Subcellular localization includes both the cytoplasm and the nucleus, consistent with its role in controlling proteolysis in multiple compartments.
- Post-translational modifications include acetylation, and the protein has been identified through direct protein sequencing and proteomics approaches.
- Mutations in CSTB are associated with progressive myoclonus epilepsy (EPM1), a neurodegenerative disorder, highlighting its role in neuronal function.
- The mature protein has a molecular weight of approximately 11 kDa, as determined by sequence analysis.
- Additional keywords linking to disease variants include epilepsy and neurodegeneration, underscoring its clinical relevance.
Experimental Guidance and Technical Tips
- The immunogen is a synthetic peptide covering the N-terminal region (amino acids 1–98) of full-length human Cystatin B, suggesting the antibody likely recognizes the native protein.
- For Western blot analysis, a band around 11 kDa is expected; consider using 12–15% SDS-PAGE gels and optimized transfer conditions for small proteins.
- Cross-reactivity with mouse and rat Cystatin B has been reported; validation in the relevant sample system is recommended.
- In ELISA, coating antigen and antibody concentration should be titrated to achieve optimal signal-to-noise ratio; this antibody is suitable for both direct and sandwich ELISA formats.
- Since Cystatin B is itself a protease inhibitor, standard sample preparation may not require additional thiol protease inhibitors, but confirm experimentally.
CamelBio: Your One-Stop Sourcing Bridge
As a dedicated one-stop sourcing platform, CamelBio provides diagnostic manufacturers and research laboratories with consistent access to critical IVD raw materials, including this high-quality anti-Cystatin B monoclonal antibody. Whether you need validated antibody pairs for protease-related assays, bulk ancillary reagents, or rare target sourcing, CamelBio supports your workflow from early-stage development to clinical application. For targets involved in neurodegeneration and protease inhibition pathways, our team can assist in selecting optimized immunoreagents to accelerate your diagnostic kit development.
Product Datasheet
Anti-Cystatin B Monoclonal Antibody for WB, ELISA - P04080
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!